EarningsORIONPHARM
ORIONPHARM Earnings Update
Announcement summary
- What happened
- ORIONPHARM published a corporate disclosure on 2 May 2017. Read the full announcement for details.
- Company
- Orion Pharma Ltd.
- Announcement published
Original announcement
(Q3 Un-audited): Consolidated EPS was Tk. 0.56 for January-March 2017 as against Tk. 0.33 for January-March 2016; Consolidated EPS was Tk. 3.02 for July'16-March'17 as against Tk. 2.33 for July'15-March'16. Consolidated NOCFPS was Tk. 8.54 for July 2016-March 2017 as against Tk. 10.23 for July 2015-March 2016. Consolidated NAV per share (including and excluding Revaluation Surplus) was Tk. 71.14 and Tk. 62.63 respectively as on March 31, 2017 and Tk. 69.99 and Tk. 61.34 respectively as on June 30, 2016.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616acf0d5a6b00004005f7d6
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from ORIONPHARM
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.